Urokinase plasminogen activator (uPA, PLAU) mRNA, a classical molecule of the plasminogen activation system, contributes to various cancer processes, including tumor proliferation, invasion, metastasis, and angiogenesis (135, 136). This evidence concerns the gene PLAU and cancer.